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L1-CAM (L1 cell-adhesion molecule), or more simply L1,
plays an important role in the progression of human carcinoma.
Overexpression promotes tumour-cell invasion and motility,
growth in nude mice and tumour metastasis. It is feasible that
L1-dependent signalling contributes to these effects. However,
little is known about its mechanism in tumour cells. We
reported previously that L1 is cleaved by ADAM (a disintegrin
and metalloprotease) and that the cytoplasmic part is essential
for L1 function. Here we analysed more closely the role of
proteolytic cleavage in L1-mediated nuclear signalling. Using
OVMz carcinoma cells and L1-transfected cells as a model, we
found that ADAM10-mediated cleavage of L1 proceeds in lipid
raft and non-raft domains. Thecleavageproduct, L1-32, is further
processed by PS (presenilin)/γ-secretase to release L1-ICD, an
L1 intracellular domain of 28 kDa. Overexpression of dominant-
negative PS1 or use of a speciﬁc γ-secretase inhibitor leads to an
accumulation of L1-32. Fluorescence and biochemical analysis
revealed a nuclear localization for L1-ICD. Moreover, inhibition
of ADAM10 and/or γ-secretase blocks nuclear translocation of
L1-ICDandL1-dependentgeneregulation.Overexpressionofre-
combinant L1-ICD mediates gene regulation in a similar manner
to full-length L1. Our results establish for the ﬁrst time that
regulatedproteolyticprocessingbyADAM10andPS/γ-secretase
is essential for the nuclear signalling of L1 in human carcinoma
cell lines.
Key words: a disintegrin and metalloprotease 10 (ADAM10),
L1 cell-adhesion molecule (L1-CAM), nuclear translocation,
presenilin (PS)/γ-secretase activity, raft, signalling.
INTRODUCTION
L1-CAM (L1 cell-adhesion molecule), or more simply L1, is a
200–220-kDa transmembrane glycoprotein of the immunoglo-
bulin superfamily. Initially, it was found to be involved in the
regulation of cell migration, axon outgrowth and guidance during
the development of the nervous system [1]. However, more recent
studies have shown that L1 also plays a role in the ontogeny of
human tumours and its expression is linked to poor prognosis [2–
5].ThemechanismbywhichL1contributestotumourprogression
is not clearly established.
PreviousstudieshavedemonstratedthatL1enhancesgrowthof
tumour cells in NOD/SCID (non-obese diabetic severe combined
immunodeﬁciency)mice,augmentstumourcellmotilityonextra-
cellular-matrix proteins and invasiveness in matrigel assays, and
promotesformationoflivermetastases[6,7].InterferencewithL1
expressionbygeneticmanipulationwasfoundtobegrowthinhib-
itory in vitro [8]. Similar results were reported for L1 antibodies
[8,9]. Importantly, a number of studies have demonstrated that
L1 can alter gene expression [7–9]. Although ERK (extracellular-
signal-regulated kinase) activation appears to be required for this
process, it is unclear if additional factors are involved.
We demonstrated previously that the ectodomain of L1 is
cleaved at the plasma membrane by ADAM10 (A Disintegrin
AndMetalloprotease10)[6,10,11].TheinvolvementofADAM10
was conﬁrmed in a study using ADAM-deﬁcient ﬁbroblastic cell
lines established from knock-out mice [12]. This investigation
suggested that ectodomain cleavage by ADAM10 is followed by
intramembrane PS (presenilin)/γ-secretase-dependent cleavage,
leading to the generation of L1-ICD (L1 intracellular domain)
[12].TheprocessofRIP(regulatedintramembraneproteolysis)is
an essential step in a variety of signalling pathways [13]. Nuclear
translocation and transcriptional regulation of proteins such as
Notch,CD44andAPP(amyloidprecursorprotein)wereshownto
dependonADAM-mediatedcleavagefollowedbyPS/γ-secretase
activity [13]. We thus hypothesized that proteolytic processing
might contribute to L1-signalling.
Lipid rafts are microdomains within the plasma membrane that
are enriched in cholesterol and sphingolipids [14]. They have
gained attention as platforms for the proteolytic processing of
several proteins, including APP [15,16] and the cellular prion
protein (PrP
c) [17]. Interestingly, it has already been shown
that members of the L1 family are associated with cholesterol-
enriched microdomains [18,19].
Abbreviations used: ADAM, a disintegrin and metalloprotease; APP, amyloid precursor protein; CHO, Chinese-hamster ovary; CRABPII, cellular retinoic
acid-binding protein II; CTF, C-terminal fragment; DAPT, N-[N-(3,5-diﬂuorophenacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester (also known as presenilin
inhibitor IX); DRM, detergent-resistant membrane; ECL®, enhanced chemiluminescence; ERK, extracellular-signal-regulated kinase; FCS, fetal-calf serum;
FNIII, ﬁbronectin III; HEK-293, human embryonic kidney-293; hL1, human L1; HRP, horseradish peroxidase; ICD, intracellular domain; LAMP-1, lysosomal-
associated membrane protein 1; L1, L1 cell-adhesion molecule; L1cyt, the cytoplasmic part of L1; mAb, monoclonal antibody; MDK, midkine or neurite
growth-promoting factor 2; MT1-MMP, membrane type-1 matrix metalloproteinase; pAb, polyclonal antibody; PS(1), presenilin(-1); qRT-PCR, quantitative
real-time PCR; RIP, regulated intramembrane proteolysis; siRNA, small interfering RNA; TACE, tumour-necrosis factor-α converting enzyme; TAPI-0,
N-(R)-[2-(hydroxyaminocarbonyl)methyl]-4-methylpentanoyl-L-naphthylalanyl-L-alanine amide.
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In the present study we have analysed more closely the role
of proteolytic processing for L1 signalling. We observed in
OVMz cells that ADAM10-mediated cleavage of L1 proceeds
in both lipid rafts and in non-raft domains. In addition, we
provideevidencethatPS/γ-secretaseactivityisinvolvedinfurther
processing of the metalloprotease cleavage fragment. Pharma-
cological inhibition of ADAMs or γ-secretase activity blocked
nuclear translocation of L1 and abrogated L1-dependent gene
regulation. Moreover, speciﬁc targeting of ADAM10 and PS1
with siRNA (small interfering RNA) affected transcription of L1-
dependent genes. We also demonstrate that overexpression of
recombinant L1-ICD mediates gene regulation similarly to full-
length L1. Our results establish, to our knowledge for the ﬁrst
time, that proteolytic processing by ADAMs and PS/γ-secretase
is essential for nuclear signalling of L1 in cancer cell lines.
EXPERIMENTAL
Cells and DNAs
The ovarian carcinoma cell line OVMz and the stably transfected
cell lines HEK-293-hL1 (human embryonic kidney-293-human
L1) and CHO-hL1 (Chinese-hamster ovary-hL1) have been
described previously [6,20]. Human pancreatic adenocarcinoma
cells PT45-PI were described in [21]. Plasmids encoding PS1
and the dominant negative mutant (D385N) were obtained
from Professor Dr Christian Haass (Laboratory for Alzheimer’s
and Parkinson’s Disease, Department of Biochemistry, Adolf
Butenandt Institute, Ludwig Maximilians University, Munich,
Germany). A fragment encoding L1cyt (the cytoplasmic part of
L1) from position Gly
1148 to the C-terminus was constructed by
PCR and both L1cyt and full-length L1 were inserted into the
retroviralvectorpBMIres-Puro.Thetransductionofcelllineswith
retroviral vectors and selection with puromycin was as described
previously [22]. All cell lines were cultivated in Dulbecco’s
modiﬁed Eagle’s medium supplemented with 10% (v/v) FCS
(fetal-calf serum) at 37◦C, 5% CO2 and 100% humidity.
Chemicals and antibodies
Antibodies to the ectodomain (L1-11A) or cytoplasmic domain
(pcytL1) of human L1 have been described [6,9]. The mAb
(monoclonal antibody) 74 5H7 [23] to the cytoplasmic part
of L1 was kindly provided by Professor Vance P. Lemmon
(Miami Project to Cure Paralysis and Neuroscience Program,
University of Miami Miller School of Medicine, Miami,
FL, U.S.A.). The mAbs to the ectodomains of ADAM10
(MAB1427) and TACE (tumour-necrosis factor-α converting
enzyme) (MAB9301) were from R&D (Wiesbaden, Germany),
C-terminal pAbs (polyclonal antibodies) were from Chemicon
International (AB19026 and AB19027 respectively). mAb 11G2
toADAM10wasfromAbcam(Cambridge,U.K.).Theantibodies
to nucleoporin, BIP/GRP78 (immunoglobulin heavy chain
binding protein/78 kDa glucose regulatory protein), the small
GTPaserab11,ERKandphospho-ERKwerepurchasedfromBD-
Transduction (Heidelberg, Germany). The antibody to LAMP-1
(lysosomal-associated membrane protein 1) was from Santa Cruz
(Heidelberg,Germany).ThepAbtotheC-terminusofPS(P7854)
was from Sigma (Taufkirchen, Germany). Secondary antibodies
were obtained from Dianova (Hamburg, Germany).
Biochemical analysis
The analysis of L1 cleavage was carried out as described
previously [24]. Brieﬂy, supernatants of a conﬂuent cell
monolayer were collected and subjected to precipitation with
trichloroacetic acid. Cells were removed from the tissue-culture
plastic surface with PBS/5 mM EDTA. Cell pellets were lysed
in lysis buffer (20 mM Tris/HCl, pH 8.0, containing 1% β-octyl
glycopyranoside, 150 mM NaCl and 1 mM PMSF), cleared by
centrifugation and mixed with twice-concentrated reducing SDS-
sample buffer. SDS/PAGE under reducing conditions and transfer
of separated proteins to Immobilon membranes using semi-dry
blotting was as described previously [24]. After blocking with a
5% (w/v) solution of dried skimmed-milk powder in TBS (Tris-
buffered saline; 10 mM Tris/HCl and 150 mM NaCl, pH 8.0),
the blots were incubated with the respective primary antibody
followed by HRP (horseradish peroxidase)-conjugated secondary
antibody and enhanced chemiluminescence detection.
Isolation and analysis of membrane lipid rafts
Cells (approx. 1×10
7) were lysed in 10 mM Tris/HCl, pH 8.0,
containing 1% Triton-X100, 150 mM NaCl, 1 mM PMSF and
1 μg/ml aprotinin at 4◦C. The lysate was mixed with an
equal volume of sucrose solution (85%, w/v, in TBS contain-
ing Boehringer Complete
TM) and 0.5 ml was transferred to a
centrifuge tube. A step gradient was prepared by overlaying with
3m lo f3 5% sucrose in TBS, followed by 0.5 ml of 5% sucrose
inTBSasdescribedin[25].Thegradientwascentrifugedfor18 h
at 200000 g in a Beckman SW60 rotor. Fractions (0.5 ml each)
werecollectedfromtopofthegradientandprecipitatedwithchlo-
roform/methanol as described in [25]. Samples were dissolved in
SDS-sample buffer. SDS/PAGE, Western blotting and enhanced
chemiluminescence were performed as described in [24].
siRNA transfection
siRNAs targeting L1, ADAM10 and TACE were described in
[11,26]. siRNA speciﬁc for PS1 (AAGGUCCACUUCGUAUG-
CUGGTT) was purchased from Euroﬁns MWG GmbH
(Ebersberg, Germany). OVMz cells were transfected with Oligo-
fectamine
TM (Invitrogen)accordingtothemanufacturer’sprotocol.
Quantitative real-time PCR
RNA was isolated using the RNAeasy Mini Kit (Qiagen, Hilden,
Germany). For qRT-PCR (quantitative real-time PCR) the cDNA
waspuriﬁedonMicrospinG-50columns[AmershamBiosciences
(now GE Healthcare), Freiburg, Germany] and quantiﬁed using a
NanoDrop spectrophotometer (ND-1000; Kisker-Biotechnology,
Steinfurt, Germany). Primers for qRT-PCR were designed with
the DNA Star Program and were produced by Euroﬁns MWG.
β-actin was used as an internal standard. The PCR reaction
was performed with the SYBR Green Master Mix (Applied
Biosystems, Darmstadt, Germany). The sequences of the primers
used are available from P.A. on request.
Flow cytometry and immunoﬂuorescence microscopy
The staining of cells with mAbs and phycoerythrin-conjugated
secondary antibodies has been described [6]. Cells were analysed
with a FACScan ﬂow cytometer using Cellquest software (BD
Biosciences, Heidelberg, Germany). For confocal microscopy,
cellswereﬁxedwith3%(v/v)paraformaldehyde/PBSfor20 min,
quenched for 10 min in 50 mM NH4Cl, permeabilized for 5 min
with methanol (−20◦C) and stained with pcytL1 and Alexa488-
conjugated anti-rabbit IgG. Cell preparations were mounted in
Mowiol and images were acquired using a confocal laser imaging
system (LSM 510; Carl Zeiss MicroImaging). Quantiﬁcation was
performed using ImageJ software. Nuclei were bordered in phase
contrast and the pixel number within the encircled area was
determined.
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Figure 1 L1 cleavage in OVMz cells is mediated by ADAM10
(A) Schematic illustration of L1 cleavage fragments. Abbreviations: Ig, immunoglobulin; PPC, proprotein convertase. (B) OVMz cells were lysed in 1% Triton X-100. The sample was mixed with an
equalvolumeof85%sucrose,placedonthebottomofacentrifugetubeandoverlaidwithastepwisesucrosegradientasdescribedintheExperimentalsection.Afterultracentrifugation,fractionswere
harvested from the top of the gradient and analysed by SDS/PAGE and Western blotting. Fractions were probed with pcytL1 to the cytoplasmic portion of L1, followed by HRP-conjugated secondary
antibodies and ECL® detection. The nomenclature of L1 cleavage fragments is as described previously [6]. Gradient fractions were re-probed with antibodies to fyn and ADAM10. The mature form
(66kDa) and the pro-form (97kDa) are indicated. (C) OVMz cells were transfected with siRNA speciﬁc for ADAM10 or ADAM17. Expression levels were analysed 48h after transfection by ﬂow
cytometry with mAbs to the ectodomains of ADAM10 or ADAM17. Abbreviation: scr, scrambled control siRNA. (D) siRNA-transfected cells were lysed in Triton X-100 and sucrose-density-gradient
centrifugation was performed as described above. Gradient fractions were analysed by Western blot with pcytL1 as described above. Numbers indicate relative band intensities. The asterisk (*)
indicates non-speciﬁc bands.
Puriﬁcation of nuclei
Puriﬁcationofnucleiwasperformedasdescribedin[27].Nuclear
extractswerepreparedbyincubationofthepuriﬁednucleiinhigh-
salt buffer [0.42 M NaCl/20 mM Hepes (pH 7.9)/ 25% (v/v/)
glycerol] for 30 min at 4◦C, followed by centrifugation (10000 g
for 30 min at 4◦C).
Statistical analysis
For the analysis of statistical signiﬁcance, the Student’s t test was
used.
RESULTS
Cleavage of L1 in lipid raft and non-raft domains
L1 is expressed as a full-length molecule (L1-220), but can be
proteolyticallycleavedatdifferentsitesasoutlinedinFigure1(A).
Cleavage in the third FNIII (ﬁbronectin III) domain generates
a fragment of 85 kDa (L1-85). In addition, a 32 kDa (L1-32)
fragment results from membrane proximal cleavage mediated
by ADAM10. We initially investigated whether L1-220 was
associated with lipid rafts using solubilization in Triton X-100
and sucrose-density-gradient centrifugation. In OVMz cells a
signiﬁcant portion of full-length L1-220 (between 20 and 30%,
n>10) was recovered in the low-density DRM (detergent-
resistant membrane) fraction, identiﬁed by the marker tyrosine-
speciﬁc phosphotransferase fyn (Figure 1B).
The L1-32 cleavage fragment was detected in both lipid
raft (fraction no. 2) and non-raft fractions ﬂoating above the
loading zone (fraction no. 7). A similar distribution of L1-220
and L1-32 was found in other cell lines such as the breast
carcinoma cell line AR [24], stably transduced CHO-hL1, HEK-
293-hL1andpancreatic-carcinomaPT45-PI-hL1cells(resultsnot
shown).
c   The Authors Journal compilation c   2009 Biochemical Society © 2009 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commerical use, distribution and reproduction in any medium, provided the original work is properly cited.394 S. Riedle and others
Cleavage of L1 by ADAM10 in lipid rafts and non-rafts
The above results indicated that L1 distributes between lipid raft
and non-raft domains and that membrane proximal cleavage is
apparent in both. We next analysed the distribution of ADAM10,
the protease responsible for constitutive shedding of L1. A
subpopulation of mature ADAM10 (66 kDa) was associated with
lipid rafts and co-localized with L1-32 (Figure 1B). In addition,
ADAM10 was detected in the bottom fraction of the gradient.
To test whether ADAM10-mediated processing is restricted to
lipid rafts, we targeted ADAM10 with a speciﬁc siRNA. As
a control, cells were treated with siRNA to ADAM17, which
catalyses the induced shedding of L1 [11]. Efﬁcient knock-down
was conﬁrmed by ﬂow cytometry (Figure 1C) and Western-blot
analysis (results not shown). Down-regulation of ADAM10, but
not ADAM17, decreased the level of L1-32 in both lipid raft and
non-raft fractions (Figure 1D). These results suggested that
constitutive shedding of L1 in OVMz cells is independent of
lipid-raft localization.
L1-32 co-fractionates with late endosomal marker LAMP-1
We noticed that fraction no. 7 of the raft gradient contained
L1-32, whereas L1-220 was hardly detectable (Figure 1B). To
further deﬁne the composition of fraction no. 7, we used an
established fractionation protocol to separate early and late
endosomes and heavy membranes (Figure 2A) [28]. L1-32 was
enriched at the 8/25%-sucrose interface, where it co-fractionated
withthelateendosomalmarkerLAMP-1(Figure2B).Themarker
protein EEA-1 (early endosomal antigen 1) was not detected,
suggesting that fraction no. 7 was devoid of early endosomes. By
contrast, rab11, a marker for recycling endosomes, was detected
at the 25/35% interface. Co-fractionation of LAMP-1 and L1-32
suggested that late endosomes/lysosomes are candidate sites for
the proteolysis of L1.
L1-32 is a substrate for PS/γ-secretase activity
Previous work in ﬁbroblastic mouse cell lines had shown that
L1-32 undergoes further processing by PS/γ-secretase [12]. The
active γ-secretase complex is associated with lipid rafts [29].
The PS1 holoprotein (48 kDa) is endoproteolysed to generate
N-terminal(25–25 kDa)andC-terminal(18 kDa)fragments.Both
fragmentsarefoundinhigh-molecular-masscomplexeswithother
integral membrane proteins, which together constitute the active
γ-secretase.
When we analysed the distribution of PS1 in sucrose-gradient
fractions, the 48 kDa holoprotein was detected in lipid rafts,
whereas the 18 kDa C-terminal fragment was mainly found
in the bottom fractions (Figure 3A). We used the speciﬁc PS
inhibitor IX (DAPT {N-[N-(3,5-diﬂuorophenacetyl)-L-alanyl]-
(S)-phenylglycine t-butyl ester}) to investigate cleavage of L1
in OVMz cells. The treatment led to an increase in L1-32
(Figure3B).ThiswasnotduetoenhancedADAM10cleavage,but
rather the effect of blocking L1-32 processing, since the amount
of soluble L1 in the medium was not increased (Figure 3C). In
agreement with this notion, the accumulation of L1-32 by DAPT
was also apparent when metalloprotease cleavage was blocked by
theinhibitorTAPI-0{N-(R)-[2-(hydroxyaminocarbonyl)methyl]-
4-methylpentanoyl-L-naphthylalanyl-L-alanine amide}, ruling
out the possibility that DAPT itself activated metalloproteinase
cleavage (results not shown). Overexpression of PS1 led to
a signiﬁcant decrease in L1-32 in both lipid raft and non-
raft domains. By contrast, dominant-negative PS1 (D385N)
caused the accumulation of L1-32 (see Supplementary Fig-
Figure 2 L1-32 co-fractionates with the late endosomal marker LAMP-1
(A) Fraction no. 7 of the raft gradient was harvested, diluted with PBS and subjected to further
ultracentrifugation for 2h at 100000g. The pellet was suspended in 0.5 ml of 40.6% sucrose
and loaded into the bottom of an SW60 centrifuge tube. This was overlaid with 1.5ml of 35%
sucrose, followed by 1ml of 25%sucroseand, ﬁnally, 0.5ml of 8% sucrose.Thegradient was
centrifuged for 1h at 160000g in a Beckman SW60 rotor. Fractions (1ml each) were collected
from the top of the gradient and precipitated with chloroform/methanol. Late endosomes (LE)
were enriched at the 8/25%-sucrose interface, early endosomes (EE) at the 25/35% interface
and heavy membranes (HM) between 35 and 40.6%. (B) Gradient fractions were probed with
pcytL1 and antibodies (α-) to LAMP-1 and rab11.
ure S1 at http://www.BiochemJ.org/bj/420/bj4200391add.htm),
an observation that supports a role for PS1 in L1-processing.
It was reported previously that PS/γ-secretase cleavage of L1-
32 released a smaller C-terminal fragment of 28 kDa in mouse
ﬁbroblasts[12].InlysatesofOVMzorHEK-293-hL1cells,L1-28
wasdifﬁculttodetect,mostprobablybecauseofrapiddegradation
and/or low abundance. Previous studies have indicated that the
ICDs of γ-secretase-cleaved proteins are rapidly degraded by
cytosolic proteases [30,31].
To directly prove that L1-32 is a substrate for γ-secretase,
we analysed the processing of L1-32 in microsomal membranes
to exclude degradation by cytosolic proteases. CHO-hL1
cells were cultivated for 16 h in the presence of DAPT or
DMSO and membranes were isolated and assayed for in vitro
γ-secretase activity [32]. Isolated membranes were incubated
for 2 h at 37◦C and the membranous and soluble fractions
were separated by ultracentrifugation. We identiﬁed L1-28 in the
supernatant fraction (Figure 3D, lane 2) of membranes isolated
from DMSO-treated cells. By contrast, no such fragment was
detected in membranes prepared from cells incubated with the PS
inhibitor DAPT.Instead, L1-32was foundinthemembrane pellet
(Figure 3D, lane 3). Similar observations were made in OVMz
cells (results not shown). These ﬁndings suggested that L1-32 is
further cleaved by γ-secretase, resulting in the release of L1-28,
representing the L1-ICD without the membrane portion.
Nuclear accumulation of L1-ICD
Consecutive cleavage by both enzymes is a hallmark of Notch,
APP and CD44 signalling, which is followed by translocation
of the ICD to the nucleus [13]. As L1 affects gene expression,
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Figure 3 PS/γ-secretase inhibitors block L1-32 processing
(A) OVMz cells were subjected to sucrose-density-gradient centrifugation as described in Figure 1 and the distribution of PS1 was determined. (B) OVMz cells were incubated for 24h with the PS
inhibitor DAPT or the solvent DMSO. Cell lysates were prepared in lysis buffer containing Triton X-100 and sucrose-density-gradient centrifugation was carried out as described above. Gradient
fractionswereanalysedbyWesternblottingwithpcytL1,followedbyHRP-conjugatedsecondaryantibodiesandECL® detection.(C)OVMzcellsweretreatedfor24hwithPSinhibitorIX/DAPTorthe
solventDMSOandlysateswereanalysedwithpcytL1.SolubleL1wasprecipitatedfromthetissue-culturemediumanddetectedbymAbL1-11AtotheectodomainofL1,followedbyHRP-conjugated
secondary antibodies and ECL® detection. (D) Cells were grown for 48h at 37◦C in the presence of DAPT or DMSO. Isolated membranes were incubated for 2h at 37◦C and separated into pellet
or supernatant (SN) fractions by ultracentrifugation. Lanes 1 and 2 show membranes isolated from DMSO-treated cells (vehicle); lanes 3 and 4 show membrane preparations from cells incubated
with DAPT. Numbers indicate relative band intensities. The asterisk (*) indicates non-speciﬁc bands.
we investigated the nuclear localization of L1-ICD. Nuclei were
puriﬁed using a well-established protocol [27]. The purity of the
nuclear fractions was examined by Western blotting using marker
proteins. A representative puriﬁcation is shown in Figure 4(A).
We observed that isolated nuclei were not contaminated
by cytosolic proteins (marker moesin) or endoplasmic-
reticulum-speciﬁc proteins (BiP/GRP78 marker). Nucleoporin
(a nuclear marker) was exclusively present in the nuclear
fraction. Using pcytL1 antibody to the cytoplasmic portion
of L1, we detected L1-ICD in the nuclear fraction of OVMz
(Figure 4B). When isolated nuclei were extracted with high
salt and separated into soluble and insoluble fractions by
centrifugation, L1-ICD was found exclusively in the soluble
fraction. The L1-ICD fragment was also detected in HEK-293-
hL1 but was absent in L1-negative HEK-293 cells (Figure 4C).
Nuclear translocation of L1 is blocked by inhibitors of
metalloproteases and PS/γ-secretase
We performed confocal microscopy to verify the nuclear
localization of L1. Using pcytL1 to the cytoplasmic portion of
L1, staining was detected in the cytoplasm and the nucleus
of CHO-hL1 and OVMz cells that was absent in CHO control
cells (Figure 4D). Next, we studied whether the inhibition
of metalloprotease and/or PS activity could block L1 nuclear
translocation. Treatment with the single compounds or in
combination caused a decrease of L1 staining in the nucleus
(Figure 5A). Quantiﬁcation by image analysis revealed a time-
dependent decrease of L1 nuclear staining that was detectable
after 48 h of treatment and was even more pronounced after 72 h
(Figures 5B, 5C and 5D).
Metalloprotease and PS cleavage are essential for L1-mediated
gene regulation
We investigated whether inhibition of L1-processing affects L1-
dependenttranscriptionalregulation.Wehaverecentlyidentiﬁeda
set of transcripts in HEK-293 cells, including CRABPII (cellular
retinoic acid-binding protein II), β3 integrin and cathepsin B,
which are regulated by expression of L1 [9]. HEK-293 and HEK-
293-hL1 cells were grown for 96 h in the presence of DAPT,
TAPI-0 or both inhibitors. qRT-PCR analysis showed that L1-
regulated transcription of cathepsin B and CRABPII was blocked
by TAPI-0 or DAPT, or both (Figure 6A).
AsERKactivationappearstoberequiredforL1-mediatedtran-
scriptional regulation, we analysed the phosphorylation of ERK
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Figure 4 Nuclear translocation of L1-ICD
(A) Purity of isolated nuclei as revealed by marker-protein analysis. (B) L1-ICD in the nucleus. OVMz cells were grown in 10% FCS, and nuclei were prepared and analysed by Western blotting with
pcytL1 (lane 1). Isolated nuclei were extracted with 0.42M NaCl, and soluble proteins (lane 2) and insoluble membranes (lane 3) were separated by centrifugation. (C) HEK-293 and HEK-293-hL1
cells were cultivated in 10% FCS, and nuclei were isolated and analysed by Western blotting with pcytL1. (D) Nuclear localization of L1 in CHO-hL1 cells (middle row) and OVMz cells (bottom
row). L1-negative CHO cells were used as control (top row). Cells were ﬁxed with 3% paraformaldehyde, permeabilized with methanol (−20◦C) and stained with pcytL1 and Alexa488-conjugated
anti-rabbit IgG. Note that methanol treatment eliminates membranous L1 staining, but leaves intact intracellular and nuclear staining. The asterisk (*) indicates non-speciﬁc bands.
in treated cells. Importantly, neither compounds affected ERK
activation in HEK-293 or HEK-293-hL1 cells (Figure 6B). These
results clearly showed that the changes in L1-mediated gene
regulation were independent of ERK.
Cleavage of L1 is essential for L1-mediated gene regulation
in carcinoma cells
To extend the above ﬁndings on ovarian carcinoma cells, we
transiently down-regulated L1 in OVMz cells (Figure 7A) and
screened for genes that were differentially regulated compared
with mock-transfected cells. DNA-array analysis identiﬁed 282
genesoutof46713thatwereup-ordown-regulated(S.Wolterink,
unpublishedwork).L1-dependentexpressionofasetofgeneswas
conﬁrmed by qRT-PCR. Figure 7(B) shows altered expression
levels of transcripts for MDK (midkine or neurite growth-
promoting factor 2) and β3 integrin after knock-down of L1 by
speciﬁc siRNA.
To corroborate that consecutive cleavage of L1 is essential for
L1-mediated gene regulation, OVMz cells were transfected with
siRNAs targeting ADAM10 or PS1. Efﬁcient down-regulation
of ADAM10 and PS1 was conﬁrmed by Western blotting
(Figure 7C). Targeting of PS1 caused an accumulation of L1-
32 (results not shown), an observation in agreement with what
has been observed after overexpression of dominant-negative
PS1 (D385N) (see Supplementary Figure S1) or treatment with
DAPT (see Figure 3B). Down-regulation of ADAM10 or PS1
affected transcription of MDK and β3 integrin similarly to down-
regulation of L1 (Figure 7D).
Recombinant L1-ICD mediates transcriptional regulation
On the basis of these ﬁndings we hypothesized that an artiﬁcal
L1-ICD might be able to promote L1-dependent transcriptional
regulation. To test this, we constructed L1cyt, a cytoplasmic
fragment of L1 lacking the ectodomain and transmembrane
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Figure 5 Inhibitors of metalloproteases and PS block L1 nuclear translocation
(A) CHO-hL1 cells were treated for 72h with TAPI-0, DAPT or TAPI-0/DAPT and nuclear localization of L1 was analysed. Cells were ﬁxed with 3% paraformaldehyde, permeabilized with methanol
(−20◦C), stained with pcytL1 and Alexa488-conjugated anti-rabbit IgG and analysed by confocal microscopy. Note that methanol treatment abolishes membranous L1 staining, but leaves intact
intracellular and nuclear staining. (B–D) Quantiﬁcation of nuclear staining of L1 in CHO-hL1 cells treated with the indicated compounds for 48 or 72h. For each analysis, ten nuclei were encircled
and the pixel number in the nuclei was determined. CHO-hL1 cells were used because they were easier to handle in microscopic analysis.
region. Cells were stably transduced with L1cyt and full-length
L1. Intracellular staining using mAb 745H7 to the cytoplasmic
portion of L1 monitored by ﬂow cytometry showed that both
constructs were expressed at comparable levels (Figure 8A).
Western blot analysis demonstrated that the L1cyt fragment had
a size of approx. 30 kDa and migrated slightly smaller than
the L1-32 fragment generated by proteolytic cleavage of full-
length L1 (Figure 8B). Biochemically, L1cyt was detectable
in puriﬁed nuclei and was very similar in size to the L1-ICD
fragment released after γ-secretase mediated cleavage of L1-32
(Figure 8C). Importantly, L1cyt affected gene expression of
CRABPII and β3 integrin similarly to full-length L1, as shown
by qRT-PCR. Neither L1cyt nor full-length L1 altered cathepsin
B gene expression in PT45-PI cells (Figure 8D).
DISCUSSION
The cell-adhesion molecule L1 is a type 1 transmembrane protein
that is expressed in human carcinomas and melanomas and has
been linked to poor prognosis [33,34]. L1 undergoes regulated
proteolysis at the cell surface and in released exosomes, a process
that involves the metalloprotease ADAM10 [6,10,11]. Both L1
and ADAM10 were detected at the invasive front of human
colon-cancer tissue [35], and transfection of ADAM10 confers
metastaticcapabilitiesoncoloncancercellsexpressingL1[36].In
addition,ADAM10isexpressedinovariananduterinecarcinomas
in which soluble L1 is detectable in the serum [34].
Little is known about the fate of the L1-32 that remains after
membrane proximal cleavage. Numerous studies have shown
that residual transmembrane remnants become susceptible to
RIP. Many substrates for PS-dependent γ-secretase have already
been identiﬁed, such as APP [37], Notch [30], ErbB4 (v-erb-
a erythroblastic leukaemia viral oncogene homologue) [38,39],
E-cadherin [40] and CD44 [41]. They all undergo ectodomain
shedding, which is evidently a prerequisite for subsequent γ-sec-
retase cleavage. Likewise, recent studies in mouse ﬁbroblastic
cell lines demonstrated that L1 is further processed by the PS–
γ-secretase complex after initial cleavage by ADAM10 [12].
Here we provide evidence that regulated intramembrane
proteolysis of L1 is also apparent in ovarian carcinoma cells. The
decrease in PS/γ-secretase activity brought about by the speciﬁc
inhibitor DAPT or the overexpression of dominant-negative PS1
(D385N) led to the accumulation of L1-32 without a concomitant
increase in the L1 ectodomain. Moreover, we observed in an
in vitro assay that the conversion of the initial ADAM10 cleavage
fragment L1-32 into a soluble form of approx. 28 kDa is sensitive
to the γ-secretase inhibitor DAPT. In contrast with the ﬁndings
by Maretzky et al. [12], we were not able to detect L1-28 in
cell lysates, even when cells were grown in the presence of
proteasome inhibitors (results not shown). This might be due
to low abundance and/or rapid degradation of the L1 intracellular
domain in carcinoma cells. However we identiﬁed an L1 cleavage
product after enrichment of puriﬁed nuclei. The size of this
fragment was similar to that of the soluble L1-form released in
the in vitro assay described.
c   The Authors Journal compilation c   2009 Biochemical Society © 2009 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commerical use, distribution and reproduction in any medium, provided the original work is properly cited.398 S. Riedle and others
Figure 6 Inhibitors of metalloproteases and PS block L1-dependent gene regulation
(A) HEK-293 or HEK-293-hL1 cells were treated with DMSO, DAPT, TAPI-0, or both DAPT and TAPI-0, for 96h. RNA was transcribed to cDNA and expression of CRABPII and cathepsin B was
analysed by qRT-PCR. (B) Analysis of ERK phosphorylation in HEK-293 and HEK-293-hL1 cells treated with the indicated compounds.
We further analysed the role of proteolytic processing in
L1-dependent signalling. Confocal microscopy conﬁrmed that
L1-ICD can localize to the nuclei of CHO-hL1 cells. Nuclear
translocation was clearly diminished in cells treated with TAPI-
0 and DAPT, inhibitors of metalloproteases and γ-secretase
respectively. These ﬁndings suggested that L1 enters the nucleus
after initial ADAM10 cleavage, followed by RIP. We assumed
that L1-ICD in the nucleus might participate in transcriptional
regulation by analogy to what has already been described for
Notch[42].Toaddressthisquestion,weinvestigatedtheimpactof
blockingproteolyticprocessingonL1-dependentgeneregulation.
We have recently identiﬁed a number of genes that are regulated
by L1 in HEK-293 cells, such as those coding for cathepsin
B, β3 integrin, CRABPII or HOXA9 (homeobox A9) [9]. As
demonstrated here for cathepsin B and CRABPII, L1-mediated
gene regulation was blocked in the presence of speciﬁc ADAM
and PS/γ-secretase inhibitors. Moreover, speciﬁc targeting of
ADAM10 or PS1 with siRNA affected the transcription of genes,
e.g. those encoding MDK and β3 integrin, similar to knock-
down of L1 in ovarian carcinoma cells. Taken together, these
results highlight the relevance of consecutive processing for the
downstream signalling of L1.
To corroborate the role of the L1-ICD in transcriptional regula-
tion, we expressed an artiﬁcial L1-ICD lacking the ectodomain
and transmembrane region (L1cyt). Indeed, we found that
L1cyt localized to the nucleus and mediated transcriptional
regulation similarly to full-length L1. Additional analysis has
shown that L1cyt does not support cell proliferation in vitro
and tumour growth in mice as does full-length L1 (H. Kiefel,
unpublished work). These results are in agreement with
recent observations by Gavert et al. [36]. Nevertheless, our ﬁnd-
ingsunderlinetheroleofthecytoplasmicpartofL1forsignalling
and establish a link between proteolysis, nuclear transloca-
tion and L1-mediated transcriptional regulation. It is currently
not clear how L1 signal transduction by RIP relates to the
L1-dependent ERK signalling pathway previously characterized
[7,9,43]. ERK1/2 are serine-threonine kinases that phosphorylate
many cellular proteins, i.e. transcription factors, cytoskeletal
proteins, membrane proteins and other kinases [44,45]. Activated
ERK translocates from the cytoplasm to the nucleus, where it
regulates gene transcription [45]. Of note, in previous work we
have characterized a cytoplasmic L1 mutant (hL1mutTS) devoid
of the ERK phosphorylation site (Ser
1248) that does not support
L1-dependent gene regulation and ERK activation [9]. We
observed recently that L1mutTS-ICD does not translocate to the
nucleus, although it is processed by ADAM10 [46]. In the present
paper we found that DAPT or TAPI-0 treatment of L1-expressing
HEK-293 cells did not affect ERK phosphorylation (Figure 6B).
Similar observations were made when L1 was speciﬁcally
depleted using siRNA [26]. Although these results might suggest
a less important role in ERK activation, it is still possible
that L1 and ERK have to co-operate for L1 processing and/or
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Figure 7 Targeting of PS1 or ADAM10 blocks L1-dependent gene regulation
(A) OVMz cells were transfected with siRNA targeting L1. The knock-down of L1 was analysed 72h after transfection using pcytL1 and ECL® detection. (B) RNA was transcribed to cDNA and
expression of MDK and β3 integrin was analysed by qRT-PCR. (C) OVMz cells were transfected with siRNA targeting PS1 or ADAM10. Knock-down was conﬁrmed with antibodies to ADAM10
(mAb 11G2) or PS1. (D) RNA was transcribed to cDNA and expression of MDK and β3 integrin was analysed by qRT-PCR. One representative experiment is shown (n=3).
transcriptionalregulation.Furtherstudieswillneedtouncoverthe
contribution of each mechanism to the outcome of L1 signalling.
As lateral segregation of membrane proteins from their shed-
dasesbycholesterol-richmicrodomainsseemstobeamechanism
to control proteolysis [47], we investigated the importance
of L1 partition into lipid rafts for its ectodomain shedding.
Using sucrose-density-gradient centrifugation, we showed that
L1 distributes between lipid raft and non-raft domains. Moreover,
we detected the proteolytic fragment L1-32 in both lipid raft
and non-raft fractions. Knock-down of ADAM10 diminished the
cleavage fragment in both membrane domains, whereas down-
regulation of TACE had no effect. These data indicated that L1 is
cleaved by ADAM10 independently of its distribution into lipid
rafts. A similar ﬁnding was described for MT1-MMP (membrane
type-1 matrix metalloproteinase), a membrane-anchored protease
that is proteolytically released from the cell surface. The latter
processisindependentfromlipidrafts,sincebothtransmembrane
and glycosyl-phosphatidylinositol-anchored MT1-MMP are shed
[48]. Although partition of L1 into lipid rafts seems not to be cru-
cial for its ectodomain shedding, disruption of lipid raft integrity
by the cholesterol-binding drug nystatin completely abrogated
L1 processing in these microdomains (S. Riedle, unpublished
work).
L1-32 was also detected in non-raft domains ﬂoating above
the loading zone (Figure 1B). Reﬁned subcellular separation
demonstrated that L1-32 co-fractionated with LAMP-1, a marker
for late endosomes/lysosomes. By contrast, full-length L1 was
hardly detectable in this fraction. L1-32 may be delivered to
late endosomes/lysosomes selectively. It is also conceivable that
full-length L1 is completely cleaved within these compartments.
Growing evidence suggests a role for endosomes in the
proteolysis of membrane proteins [49]. Further analysis has to
deﬁne the subcellular localization of L1-cleavage. Nevertheless,
identiﬁcationofL1-32inlateendosomes/lysosomessuggeststhat
these endocytic compartments are likely candidate sites for the
proteolytic processing of L1.
Interestingly, the active γ-secretase complex is also present in
lipidrafts,althoughitseemsnottobecholesterol-dependent[29].
We therefore investigated whether the PS/γ-secretase-dependent
processing of L1 is associated with lipid rafts. Using sucrose-
density-gradient centrifugation we were unable to detect any
considerable amount of PS1 CTF (C-terminal fragment) in the
lipid raft fraction. This might be caused by the detergent used
for the preparation, since the choice of detergent is critical for
the detection of PS1 in lipid rafts. Mature components of the
γ-secretase complex are soluble in Triton X-100, but remain
insoluble in Lubrol-WX [50]. Nevertheless, we observed an
increase of L1-32 in the lipid raft fraction after DAPT treatment.
Importantly, this accumulation was not restricted to lipid rafts,
but was also apparent in non-raft domains. Overexpression
of dominant-negative PS1 (D385N) conﬁrmed these results. A
similar result was found for embryonic mouse brains, where the
majorityofPS1,nicastrin(partofthesecretasecomplex)andAPP
CTF remains soluble in Lubrol-WX [50]. Therefore our results
support the notion that PS/γ-secretase cleavage is not restricted
to proteins that are localized in lipid rafts.
The biological signiﬁcance of the lateral segregation of L1
into lipid raft and non-raft domains is presently unclear, but this
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Figure 8 An L1 cytoplasmic fragment mediates transcriptional regulation
PT45-PI cells were transduced with retroviral vectors encoding L1cyt or full-length L1. (A) Expression levels were analysed by intracellular staining with a mAb (745H7) to L1, followed by ﬂow
cytometry. (B) Western blot analysis with pcytL1, followed by HRP-conjugated secondary antibodies and ECL® detection. (C) Detection of L1-ICD in isolated nuclei. Nuclei were prepared and
immunoblotted with pcytL1 as described in the legend to Figure 4. (D) RNA was isolated and transcribed to cDNA. Expression of CRABPII, cathepsin B and β3 integrin was analysed by qRT-PCR.
One representative experiment is shown (n=3).
segregation has been reported in neuronal cells for L1 and the
related molecule neurofascin [19,51]. Our preliminary results
suggestthatraftresidentL1associateswithcaveolin-1(S.Riedle,
unpublished work). It should be noted that endocytosis of L1 via
theclathrin-mediatedpathwayhasbeenwellcharacterized[52].It
isthereforetemptingtospeculatethatdistinctendocyticpathways
are involved in the internalization of L1. Such different routes
regulate the signalling and turnover of transforming-growth-
factor-β receptor [53] and bone-morphogenic-protein receptor
[54]. Further work needs to clarify whether the segregation
of L1 into lipid raft and non-raft regions is required for its
internalization via caveolae/rafts as against clathrin-dependent
pathways.
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Figure S1 Overexpression of dominant-negative PS1 blocks processing of
L1-32
OVMz cells were transfected with wild-type PS1 or a dominant-negative mutant (D385N). After
48 h, cells were lysed in lysis buffer containing Triton X-100 and sucrose-density-gradient
centrifugation was carried out as described in the main paper. Numbers indicate relative band
intensities. The asterisk (*) indicates non-speciﬁc bands.
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